Concepedia

Alan R. Collins

AR

Statistics

Publications

52

Citations

4.5K

H-Index

29

Active since

1984

Affiliations

West Virginia University(Current)

University of California, Los Angeles

Oregon State University

Methodist Hospital

Cornell University

Alan R. Collins is an author at West Virginia University specializing in pharmacology, natural resources, and inflammation.

ORCID

Publications per year

1984–2024

52

Publications

52

Synthetic LXR ligand inhibits the development of atherosclerosis in mice

Sean B. Joseph, Elaine McKilligin, Liming Pei et al. · Proceedings of the National Academy of Sciences · 2002 · 939 citations · Full text

, , +17

Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor–Deficient Mice

Alan R. Collins, Woerner P. Meehan, Ulrich Kintscher et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2001 · 390 citations

, , +15

Angiotensin II–accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice

Dennis Bruemmer, Alan R. Collins, Grace Noh et al. · Journal of Clinical Investigation · 2003 · 280 citations · Full text

, , +14

Angiotensin II–accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice

Dennis Bruemmer, Alan R. Collins, Grace Noh et al. · Journal of Clinical Investigation · 2003 · 244 citations

, , +14

PPARδ-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis

Yasunori Takata, Joey Liu, Fen Yin et al. · Proceedings of the National Academy of Sciences · 2008 · 212 citations · Full text

, , +17

1–5 of 52